Prostate irradiation does not affect the serum prostatic acid phosphatase level

Frieman, 1978, The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial, New England Journal of Medicine, 299, 690, 10.1056/NEJM197809282991304 Heller, 1987, Prostatic acid phosphatase: its current clinical status, Journal of Urology, 137, 1091, 10.1016/S0022-5347(17)44414-4 Lachin, 1981, Introduction to sample size determination and power analysis for clinical trials, Controlled Clinical Trials, 2, 93, 10.1016/0197-2456(81)90001-5 Roy, 1971, Sodium thymolphthalein monophosphate: A new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum, Clinical Chemistry, 17, 1093, 10.1093/clinchem/17.11.1093 Royal College of Pathologists of Australasia (RCPA) (1990). Quality Assurance Programmes Pty, Ltd, Cycle 22. 207 Albion Street, Surrey Hills, NSW 2010, Australia. Whitesel, 1984, Acid Phosphatase: its influence on the management of carcinoma of the prostate, Journal of Urology, 131, 70, 10.1016/S0022-5347(17)50207-4 Yam, 1974, Clinical significance of the human acid phosphatase, American Journal of Medicine, 56, 604, 10.1016/0002-9343(74)90630-5